IMMUNOLOGY
Presented By
Soniya.S
II MSc Biochemistry
Dkm Collage For Women Vellore
The immune system is remarkable and versatile defense system
that has evolved to protect animals from invading pathogenic
microorganisms and cancer. It is able to generate an enormous
variety of cells and molecules capable of specifically recognizing
and eliminating an apparently limitless variety of foreign invaders.
These cells and molecules act together in a dynamic network
whose complexity rivals that of the nervous system.
Functionally, an immune response can be divided into two
related activities -recognition and response. Immune recognition is
remarkable for its specificity. The immune system is able to
recognize subtle chemical differences that distinguish one foreign
pathogen from another. Furthermore, the system is able to
discriminate between foreign molecules and the body’s own cells
and proteins
Once a foreign organism has been recognized, the
immune system recruits a variety of cells and molecules
to mount an appropriate response, called an effector
response, to eliminate or neutralize the organism. In this
way the system is able to convert the initial recognition
event into a variety of effector responses, each uniquely
suited for eliminating a particular type of pathogen.
 Later exposure to the same foreign organism induces a
memory response, characterized by a more rapid and
heightened immune reaction that serves to eliminate the
pathogen and prevent disease.
The Latin term immunis, meaning “exempt,” is the
source of the English word immunity, meaning the state
of protection from infectious disease.
HISTORICAL PERSPECTIVE
Chines and turks – 15 century
lady marry wortley montagu-1718
Edward jenner-1789
Louis pasteur
Pouilly-le-Fort and pasteur in 1881
EARLY STUDIES REVEALED HUMORALAND
CELLULAR COMPONENTS OF THE IMMUNE
SYSTEM
Emil von Behring and Shibsaburo Kitasato 1990
Elvin Kabat in 1930
Elie Metchnikoff in 1883
Merrill Chase in 1940
Bruce Glick in 1950
THE IMMUNE SYSTEM INCLUDES INNATE
AND ADAPTIVE COMPONENTS
Immunity the state of protection from infectious disease has both a less specific
and more specific component.
The less specific component, innate immunity, provides the first line of defense
against infection. Most components of innate immunity are present before the onset
of infection and constitute a set of disease-resistance mechanisms that are not
specific to a particular pathogen but that include cellular and molecular components
that recognize classes of molecules peculiar to frequently encountered pathogens.
Phagocytic cells, such as macrophages and neutrophils, barriers such as skin, and a
variety of antimicrobial compounds synthesized by the host all play important roles
in innate immunity. In contrast to the broad reactivity of the innate immune system,
which is uniform in all members of a species, the specific component
Adaptive immunity, does not come into play until there is an antigenic
challenge to the organism. Adaptive immunity responds to the challenge
with a high degree of specificity as well as the remarkable property of
“memory.” Typically, there is an adaptive immune response against an
antigen within five or six days after the initial exposure to that antigen.
Exposure to the same antigen some time in the future results in a memory
response: the immune response to the second challenge occurs more
quickly than the first, is stronger, and is often more effective in
neutralizing and clearing the pathogen. The major agents of adaptive
immunity are lymphocytes and the antibodies and other molecules they
produce. Because adaptive immune responses require some time to
marshal, innate immunity provides the first line of defense during the
critical period just after the host’s exposure to a pathogen. In general, most
of the microorganisms encountered by a healthy individual are readily
cleared within a few days by defense mechanisms of the innate immune
system before they activate the adaptive immune system.
INNATE IMMUNITY
Innate immunity can be seen to comprise four types of defensive barriers:
anatomic, physiologic, phagocytic, and inflammatory (Table 1-2).
Type Mechanism
Anatomic barriers
Skin Mechanical barrier retards entry of
microbes. Acidic environment (pH 3–5)
retards growth of microbes
Mucous membranes Normal flora compete with microbes for
attachment sites and nutrients. Mucus
entraps foreign microorganisms. Cilia
propel microorganisms out of body
Physiologic barriers
Temperature Normal body temperature inhibits growth of
some pathogens. Fever response inhibits
growth of some pathogens.
Low Ph Acidity of stomach contents kills most
ingested microorganisms
Chemical mediators Lysozyme cleaves bacterial cell wall.
Interferon induces antiviral state in
uninfected cells. Complement lyses
microorganisms or facilitates
phagocytosis. Toll-like receptors
recognize microbial molecules, signal
cell to secrete immunostimulatory
cytokines. Collectins disrupt cell wall of
pathogen.
Phagocytic/endocytic barriers Various cells internalize (endocytose)
and break down foreign
macromolecules. Specialized cells
(blood monocytes, neutrophils, tissue
macrophages) internalize
(phagocytose), kill, and digest whole
microorganisms.
nflammatory barriers Tissue damage and infection induce
leakage of vascular fluid, containing
serum proteins with antibacterial
activity, and influx of phagocytic cells
into the affected area
A variety of soluble factors contribute to innate immunity,
among them the soluble proteins lysozyme, interferon, and
complement.
-Lysozyme, a hydrolytic enzyme found in mucous
secretions and in tears, is able to cleave the peptidoglycan
layer of the bacterial cell wall.
-Interferon comprises a group of proteins produced by
virus-infected cells. Among the many functions of the
interferons is the ability to bind to nearby cells and induce a
generalized antiviral state.
-Complement, is a group of serum proteins that circulate in
an inactive state
CELLS THAT INGESTAND DESTROY PATHOGENS
MAKE UPA PHAGOCYTIC BARRIER TO INFECTION
 Another important innate defense mechanism is the ingestion of
extracellular particulate material by phagocytosis. Phagocytosis is one
type of endocytosis, the general term for the uptake by a cell of
material from its environment. In phagocytosis, a cell’s plasma
membrane expands around the particulate material, which may include
whole pathogenic microorganisms, to form large vesicles called
phagosomes . Most phagocytosis is conducted by specialized cells,
such as blood monocytes, neutrophils, and tissue macrophages . Most
cell types are capable of other forms of endocytosis, such as receptor-
mediated endocytosis, in which extracellular molecules are
internalized after binding by specific cellular receptors, and
pinocytosis, the process by which cells take up fluid from the
surrounding medium along with any molecules contained in it.
INFLAMMATION REPRESENTS A COMPLEX
SEQUENCE OF EVENTS THAT STIMULATES IMMUNE
RESPONSES
Tissue damage caused by a wound or by an invading pathogenic
microorganism induces a complex sequence of events collectively
known as the inflammatory response. As described above, a molecular
component of a microbe, such as LPS, may trigger an inflammatory
response via interaction with cell surface receptors. The end result of
inflammation may be the marshalling of a specific immune response to
the invasion or clearance of the invader by components of the innate
immune system. Many of the classic features of the inflammatory
response were described as early as 1600 BC, in Egyptian papyrus
writings. In the first century AD, the Roman physician Celsus described
the “four cardinal signs of inflammation” as rubor (redness), tumor
(swelling), calor (heat), and dolor (pain). In the second century AD,
another physician, Galen, added a fifth sign: functio laesa (loss of
function).
The cardinal signs of inflammation reflect the three
major events of an inflammatory response
1. Vasodilation—an increase in the diameter of blood
vessels—of nearby capillaries occurs as the vessels
that carry blood away from the affected area
constrict, resulting in engorgement of the capillary
network. The engorged capillaries are responsible
for tissue redness (erythema) and an increase in
tissue temperature.
2. An increase in capillary permeability facilitates an
influx of fluid and cells from the engorged
capillaries into the tissue. The fluid that accumulates
(exudate) has a much higher protein content than
fluid normally released from the vasculature.
Accumulation of exudate contributes to tissue
swelling (edema)
3. Influx of phagocytes from the capillaries into the tissues is
facilitated by the increased permeability of the capillaries. The
emigration of phagocytes is a multistep process that includes
adherence of the cells to the endothelial wall of the blood vessels
(margination), followed by their emigration between the
capillaryendothelial cells into the tissue (diapedesis or extravasation),
and, finally, their migration through the tissue to the site of the
invasion (chemotaxis). As phagocytic cells accumulate at the site and
begin to phagocytose bacteria, they release lytic enzymes, which can
damage nearby healthy cells. The accumulation of dead cells,
digested material, and fluid forms a substance called pus.
ADAPTIVE IMMUNITY
Adaptive immunity is capable of recognizing and selectively eliminating specific
foreign microorganisms and molecules (i.e., foreign antigens). Unlike innate immune
responses, adaptive immune responses are not the same in all members of a species
but are reactions to specific antigenic challenges. Adaptive immunity displays four
characteristic attributes:
Antigenic specificity
Diversity
Immunologic memory
Self/nonself recognition
-The antigenic specificity of the immune system permits it to distinguish subtle
differences among antigens. Antibodies can distinguish between two protein
molecules that differ in only a single amino acid.
-The immune system is capable of generating tremendous diversity in its recognition
molecules, allowing it to recognize billions of unique structures on foreign antigens.
-Once the immune system has recognized and responded to an
antigen, it exhibits immunologic memory; that is, a second
encounter with the same antigen induces a heightened state of
immune reactivity. Because of this attribute, the immune system can
confer life-long immunity to many infectious agents after an initial
encounter.
-Finally, the immune system normally responds only to foreign
antigens, indicating that it is capable of self/nonself recognition.
The ability of the immune system to distinguish self from nonself
and respond only to nonself molecules is essential, for, as described
below, the outcome of an inappropriate response to self molecules
can be fatal.
Adaptive immunity is not independent of innate immunity. The
phagocytic cells crucial to nonspecific immune responses are
intimately involved in activating the specific immune response.
Conversely, various soluble factors produced by a specific immune
response have been shown to augment the activity of these
phagocytic cells. As an inflammatory response develops, for
example, soluble mediators are produced that attract cells of the
immune system. The immune response will, in turn, serve to regulate
the intensity of the inflammatory response. Through the carefully
regulated interplay of adaptive and innate immunity, the two systems
work together to eliminate a foreign invader.
THE ADAPTIVE IMMUNE SYSTEM REQUIRES
COOPERATION BETWEEN LYMPHOCYTES AND
ANTIGEN-PRESENTING CELLS
 An effective immune response involves two major groups of cells: T
lymphocytes and antigen-presenting cells.
 Lymphocytes are one of many types of white blood cells produced in
the bone marrow by the process of hematopoiesis .
 Lymphocytes leave the bone marrow, circulate in the blood and
lymphatic systems, and reside in various lymphoid organs. Because
they produce and display antigenbinding cell-surface receptors,
lymphocytes mediate the defining immunologic attributes of
specificity, diversity, memory, and self/nonself recognition.
 The two major populations of lymphocytes-B lymphocytes (B cells)
and T lymphocytes (T cells)
B LYMPHOCYTES
B cell - Antibodies Receptor
B cell-Small navie B lymphocytes (without antigen)
Induces cell cycle entry(antigen activation)
lymphoblasts (DNA synthesis)
Cell division
Effector cell Memory cell
Effector B cells called plasma cells. .
Plasma cells produce the antibody in
a form that can be secreted and have
little or no membrane-bound
antibody. Although plasma cells live
for only a few days, they secrete
enormous amounts of antibody
during this time. It has been
estimated that a single plasma cell
can secrete more than 2000 molecules
of antibody per second. Secreted
antibodies are the major effector
molecules of humoral immunity
Memory B cells have a
longer life span than
naive cells, and they
express the same
membrane-bound
antibody as their parent
B cell.
T LYMPHOCYTES
T – cell arise in bone marrow and mature in thymus (migration)
T-cell have receptor – CD4 & CD8 receptor(express a unique antigen-binding
molecule, called the T-cell receptor, on its membrane.)
T-cell receptors can recognize only antigen that is bound to cell-membrane
proteins called major histocompatibility complex (MHC) molecules.
T lymphocytes
Class I MHG or CD8 &Tc (nucleoted cell) Class II MHGor CD4&TH(APC)
Class I MHC molecules, which are
expressed by nearly all nucleated cells of
vertebrate species, consist of a heavy
chain linked to a small invariant protein
called β2-microglobulin
Class II MHC molecules, which consist of an alpha
and a beta glycoprotein chain, are expressed only by
antigen-presenting cells. When a naive T cell
encounters antigen combined with a MHC molecule
on a cell, the T cell proliferates and differentiates into
memory T cells and various effector T cells
ANTIGEN-PRESENTING CELLS
Activation of both the humoral and cell-mediated branches of the immune system
requires cytokines produced by TH cells. It is essential that activation of TH cells
themselves be carefully regulated, because an inappropriate T-cell response to self-
components can have fatal autoimmune consequences. To ensure carefully regulated
activation of TH cells, they can recognize only antigen that is displayed together
with class MHC II molecules on the surface of antigen-presenting cells (APCs).
These specialized cells, which include macrophages, B lymphocytes, and dendritic
cells, are distinguished by two properties:
(1) they express class II MHC molecules on their membranes, and
(2) they are able to deliver a co-stimulatory signal that is necessary for TH-cell
activation.
Antigen-presenting cells first internalize antigen, either by phagocytosis or by
endocytosis, and then display a part of that antigen on their membrane bound to a
class II MHC molecule. The TH cell recognizes and interacts with the antigen–class
II MHC molecule complex on the membrane of the antigen-presenting cell . An
additional costimulatory signal is then produced by the antigen-presenting cell,
leading to activation of the TH cell
HUMORAL IMMUNITY BUT NOT CELLULAR IMMUNITY
IS TRANSFERRED WITH ANTIBODY
EFECTOR B-CELL
Humoral branch of the immune
system is –B cell
Prolifercationand differentiation
into antibody-secreting plasma cell
Antibody functionas the effector of
the humoral response by binding to
antigen and neutralizing
1.Cross link several antigen to
form clusters-ingested by
phagocytic cell
2.Activation of complement
system-lysis
3.Neutralize toxic or viral-coating
them-prevents binding to host cell
EFFECTOR T- CELL
Effector t cell generated in the
response to antigen are
responsible for the cell- mediated
Both activated TH cell+cytotoxic
T Lymphocytes (CTLs) serves as
effector cell in cell- imediated
immune reaction.
Cytokines secreted by TH cells
can activate various phagocytic
cell-phagocutose&kill
microorganism more effectively
CTLs participate –play important
role in the killing of virus
infected cell ,tumor cell & altered
self cell
ANTIGEN IS RECOGNIZED DIFFERENTLY
BY B AND T LYMPHOCYTES
Antigens, which are generally very large and complex, are not recognized in their entirety by lymphocytes. Instead,
both B and T lymphocytes recognize discrete sites on the antigen called antigenic determinants, or epitopes.
Epitopes are the immunologically active regions on a complex antigen, the regions that actually bind to B-cell or
T-cell receptors. Although B cells can recognize an epitope alone, T cells can recognize an epitope only when it is
associated with an MHC molecule on the surface of a self-cell (either an antigen-presenting cell or an altered self-
cell). Each branch of the immune system is therefore uniquely suited to recognize antigen in a different milieu. The
humoral branch (B cells) recognizes an enormous variety of epitopes: those displayed on the surfaces of bacteria or
viral particles, as well as those displayed on soluble proteins, glycoproteins, polysaccharrides, or
lipopolysaccharides that have been released from invading pathogens. The cell-mediated branch (T cells)
recognizes protein epitopes displayed together with MHC molecules on self-cells, including altered self-cells such
as virus-infected self-cells and cancerous cells. Thus, four related but distinct cell-membrane molecules are
responsible for antigen recognition by the immune system:
■ Membrane-bound antibodies on B cells
■ T-cell receptors
■ Class I MHC molecules
■ Class II MHC molecules
Each of these molecules plays a unique role in antigen recognition, ensuring that the immune system can recognize
and respond to the different types of antigen that it encounters.
COMPLEXANTIGENS ARE DEGRADED (PROCESSED) AND
DISPLAYED (PRESENTED) WITH MHC MOLECULES ON THE CELL
SURFACE
In order for a foreign protein antigen to be recognized by a T cell, it must be
degraded into small antigenic peptides that form complexes with class I or
class II MHC molecules. This conversion of proteins into MHC-associated
peptide fragments is called antigen processing and presentation. Whether a
particular antigen will be processed and presented together with class I MHC
or class II MHC molecules appears to be determined by the route that the
antigen takes to enter a cell
 Exogenous pathway
 Endogenous pathway
EXOGENOUS PATHWAY
Exogenous antigen is produced outside of the host cell and enters the cell by
endocytosis or phagocytosis. Antigen presenting cells (macrophages,
dendritic cells, and B cells) degrade ingested exogenous antigen into peptide
fragments within the endocytic processing pathway. Experiments suggest that
class II MHC molecules are expressed within the endocytic processing
pathway and that peptides produced by degradation of antigen in this pathway
bind to the cleft within the class II MHC molecules. The MHC molecules
bearing the peptide are then exported to the cell surface. Since expression of
class II MHC molecules is limited to antigen-presenting cells, presentation of
exogenous peptide– class II MHC complexes is limited to these cells. T cells
displaying CD4 recognize antigen combined with class II MHC molecules and
thus are said to be class II MHC restricted. These cells generally function as T
helper cells
ENDOGENOUS PATHWAY
Endogenous antigen is produced within the host cell itself. Two common
examples are viral proteins synthesized within virus-infected host cells and
unique proteins synthesized by cancerous cells. Endogenous antigens are
degraded into peptide fragments that bind to class I MHC molecules within the
endoplasmic reticulum. The peptide–class I MHC complex is then transported to
the cell membrane. Since all nucleated cells express class I MHC molecules, all
cells producing endogenous antigen use this route to process the antigen. T cells
displaying CD8 recognize antigen associated with class I MHC molecules and
thus are said to be class I MHC restricted. These cytotoxic T cells attack and kill
cells displaying the antigen–MHC class I complexes for which their receptors are
specific
ANTIGEN SELECTION OF LYMPHOCYTES
CAUSES CLONAL EXPANSION
A mature immunocompetent animal contains a large number of antigen-
reactive clones of T and B lymphocytes; the antigenic specificity of each of
these clones is determined by the specificity of the antigen-binding receptor
on the membrane of the clone’s lymphocytes. As noted above, the specificity
of each T and B lymphocyte is determined before its contact with antigen by
random gene rearrangements during maturation in the thymus or bone
marrow. The role of antigen becomes critical when it interacts with and
activates mature, antigenically committed T and B lymphocytes, bringing
about expansion of the population of cells with a given antigenic specificity.
In this process of clonal selection, an antigen binds to a particular T or B cell
and stimulates it to divide repeatedly into a clone of cells with the same
antigenic specificity as the original parent cell . Clonal selection provides a
framework for understanding the specificity and self/nonself recognition that
is characteistic of adaptive immunity. Specificity is shown because only
lymphocytes whose receptors are specific for a given epitope on an antigen
will be clonally expanded and thus mobilized for an immune response.
Self/nonself discrimination is accomplished by the elimination, during
development, of lymphocytes bearing self-reactive receptors or by the
functional suppression of these cells in adults.
Immunologic memory also is a consequence of clonal selection. During clonal
selection, the number of lymphocytes specific for a given antigen is greatly
amplified. Moreover, many of these lymphocytes, referred to as memory cells,
appear to have a longer life span than the naive lymphocytes from which they
arise. The initial encounter of a naive immunocompetent lymphocyte with an
antigen induces a primary response; a later contact of the host with antigen will
induce a more rapid and heightened secondary response. The amplified
population of memory cells accounts for the rapidity and intensity that
distinguishes a secondary response from the primary response.
a) When an animal is injected with
an antigen, it produces a primary
serum antibody response of low
magnitude and short duration,
peaking at about 10–17 days. A
second immunization with the
same antigen results in a
secondary response that is greater
in magnitude, peaks in less time
(2–7 days), and lasts longer
(months to years) than the primary
response. Compare the secondary
response to antigen A with the
primary response to antigen B
administered to the same mice.
DIFFERENCES IN THE PRIMARYAND SECONDARY RESPONSE TO
INJECTEDANTIGEN (HUMORALRESPONSE)AND TOASKIN GRAFT
(CELL-MEDIATED RESPONSE) REFLECT THE PHENOMENON OF
IMMUNOLOGIC MEMORY
(b) Results from a
hypothetical experiment in
which skin grafts from strain
C mice are transplanted to 20
mice of strain A; the grafts
are rejected in about 10–14
days. The 20 mice are rested
for 2 months and then 10 are
given strain C grafts and the
other 10 are given skin from
strain B. Mice previously
exposed to strain C skin
reject C grafts much more
vigorously and rapidly than
the grafts from strain B.
Note that the rejection of the
B graft follows a time course
similar to that of the first
strain C graft
COMPARISON OF ADAPTIVEAND INNATE
IMMUNITY
INNATE ADAPTIVE
Response time Hours Days
Specificity Limited and fixed
Highly diverse, improves
during the course of
immune response
Response response
infection
to Identical to primary
response
Much more rapid than
repeat primary response
IMMUNE DYSFUNCTIONAND ITS
CONSEQUENCES
Sometimes the immune system fails to protect the host adequately or misdirects its
activities to cause discomfort, debilitating disease, or even death. There are several
common manifestations of immune dysfunction:
■ Allergy and asthma
■ Graft rejection and graft-versus-host disease
■ Autoimmune disease
■ Immunodeficiency
Allergy and asthma are results of inappropriate immune responses, often to common
antigens such as plant pollen, food, or animal dander. The possibility that certain
substances increased sensitivity rather than protection was recognized in about 1902 by
Charles Richet, who attempted to immunize dogs against the toxins of a type of
jellyfish, Physalia. He and his colleague Paul Portier observed that dogs exposed to
sublethal doses of the toxin reacted almost instantly, and fatally, to subsequent
challenge with minute amounts of the toxin. Richet concluded that a successful
immunization or vaccination results in phylaxis, or protection, and that an opposite
result may occur—anaphylaxis—in which exposure to antigen can result in a
potentially lethal sensitivity to the antigen if the exposure is repeated. Richet received
the Nobel Prize in 1913 for his discovery of the anaphylactic response.
When the immune system encounters foreign cells or tissue, it responds
strongly to rid the host of the invaders. However, in some cases, the
transplantation of cells or an organ from another individual, although viewed by
the immune system as a foreign invasion, may be the only possible treatment
for disease. For example, it is estimated that more than 60,000 persons in the
United States alone could benefit from a kidney transplant. Because the
immune system will attack and reject any transplanted organ that it does not
recognize as self, it is a serious barrier to this potentially life-saving treatment.
An additional danger in transplantation is that any transplanted cells with
immune function may view the new host as nonself and react against it. This
reaction, which is termed graft-versus-host disease, can be fatal. The rejection
reaction and graft-versus-host disease can be suppressed by drugs, but this type
of treatment suppresses all immune function, so that the host is no longer
protected by its immune system and becomes susceptible to infectious diseases.
In certain individuals, the immune system malfunctions by losing its
sense of self and nonself, which permits an immune attack upon the host.
This condition, autoimmunity, can cause a number of chronic
debilitating diseases. The symptoms of autoimmunity differ depending
on which tissues and organs are under attack. For example, multiple
sclerosis is due to an autoimmune attack on the brain and central nervous
system, Crohn’s disease is an attack on the tissues in the gut, and
rheumatoid arthritis is an attack on joints of the arms and legs. The
genetic and environmental factors that trigger and sustain autoimmune
disease are very active areas of immunologic research, as is the search
for improved treatments.
If any of the many components of innate or specific immunity is
defective because of genetic abnormality, or if any immune function is
lost because of damage by chemical, physical, or biological agents, the
host suffers from immunodeficiency. The severity of the
immunodeficiency disease depends on the number of affected
components.
A common type of immunodeficiency in North America is a selective
immunodeficiency in which only one type of immunoglobulin, IgA, is
lacking; the symptoms may be minor or even go unnoticed. In contrast, a
rarer immunodeficiency called severe combined immunodeficiency (SCID),
which affects both B and T cells, if untreated, results in death from infection
at an early age. Since the 1980s, the most common form of
immunodeficiency has been acquired immune deficiency syndrome, or
AIDS, which results from infection with the retrovirus human
immunodeficiency virus, or HIV. In AIDS, T helper cells are infected and
destroyed by HIV, causing a collapse of the immune system
IMMUNE RESPONSE TO INFECTIOUS
DISEASES
One of the first and most important features of host innate immunity is the
barrier provided by the epithelial surfaces of the skin and the lining of the gut.
The difficulty of penetrating these epithelial barriers ensures that most
pathogens never gain productive entry into the host. In addition to providing a
physical barrier to infection, the epithelia also produce chemicals that are useful
in preventing infection. The secretion of gastric enzymes by specialized
epithelial cells lowers the pH of the stomach and upper gastrointestinal tract,
and other specialized cells in the gut produce antibacterial peptides.
A major feature of innate immunity is the presence of the normal gut flora,
which can competitively inhibit the binding of pathogens to gut epithelial cells.
Innate responses can also block the establishment of infection. For example, the
cell walls of some gram-positive bacteria contain a peptidoglycan that activates
the alternative complement pathway, resulting in the generation of C3b, which
opsonizes bacteria and enhances phagocytosis
Some bacteria produce endotoxins such as LPS, which stimulate
the production of cytokines such as TNF-, IL-1, and IL-6 by
macrophages or endothelial cells. These cytokines can activate
macrophages. Phagocytosis of bacteria by macrophages and other
phagocytic cells is another highly effective line of innate defense.
However, some types of bacteria that commonly grow
intracellularly have developed mechanisms that allow them to resist
degradation within the phagocyte.
Viruses are well known for the stimulation of innate responses. In
particular, many viruses induce the production of interferons, which
can inhibit viral replication by inducing an antiviral response.
Viruses are also controlled by NK cells. As described in Chapter 14,
NK cells frequently form the first line of defense against viral
infections.
VIRAL INFECTIONS
A number of specific immune effector mechanisms, together with nonspecific
defense mechanisms, are called into play to eliminate an infecting virus . At the
same time, the virus acts to subvert one or more of these mechanisms to prolong its
own survival. The outcome of the infection depends on how effectively the host’s
defensive mechanisms resist the offensive tactics of the virus.
1. The innate immune response to viral infection is primarily through the
induction of type I interferons (IFN-α and IFN-β) and the activation of NK
cells.
2. Double stranded RNA (dsRNA) produced during the viral life cycle can induce
the expression of IFN-α and IFN-β by the infected cell.
3. Macrphages, monocytes, and fibroblasts also are capable of synthesizing these
cytokines, but the mechanisms that induce the production of type I interferons
in these cells are not completely understood.
4.IFN-α and IFN-β can induce an antiviral response or resistance to viral
replication by binding to the IFNα/β receptor. Once bound, IFN-α and
IFN-β activate the JAK-STAT pathway, which in turn induces the
transcription of several genes.
5.One of these genes encodes an enzyme known as 2’-5’-oligo-adenylate
synthetase [2-5(A) synthetase], which activates a ribonuclease (RNAse
L) that degrades viral RNA. Other genes activated by IFN-α/β binding to
its receptor also contribute to the inhibition of viral replication.
For example, IFN-α/β binding induces a specific protein kinase called
dsRNA-dependent protein kinase (PKR), which inactivates protein
synthesis, thus blocking viral replication in infected cells.
6.The binding of IFN-α and IFN-β to NK cells induces lytic activity,
making them very effective in killing virally infected cells. The activity
of NK cells is also greatly enhanced by IL-12, a cytokine that is
produced very early in a response to viral infection.
MANY VIRUSES ARE NEUTRALIZED BY
ANTIBODIES
Antibodies specific for viral surface antigens . Antibodies are particularly effective in protecting
against infection if they are localized at the site of viral entry into the body. Most viruses express
surface receptor molecules that enable them to initiate infection by binding to specific host-cell
membrane molecules. For example, influenza virus binds to sialic acid residues in cellmembrane
glycoproteins and glycolipids; rhinovirus binds to intercellular adhesion molecules (ICAMs); and
Epstein-Barr virus binds to type 2 complement receptors on B cells. If antibody to the viral
receptor is produced, it can block infection altogether by preventing the binding of viral particles
to host cells. Secretory IgA in mucous secretions plays an important role in host defense against
viruses by blocking viral attachment to mucosal epithelial cells. The advantage of the attenuated
oral polio vaccine, is that it induces production of secretory IgA, which effectively blocks
attachment of poliovirus along the gastrointestinal tract.
Viral neutralization by antibody sometimes involves mechanisms that operate after viral
attachment to host cells. In some cases, antibodies may block viral penetration by binding to
epitopes that are necessary to mediate fusion of the viral envelope with the plasma membrane. If
the induced antibody is of a complement-activating isotype, lysis of enveloped virions can ensue.
Antibody or complement can also agglutinate viral particles and function as an opsonizing agent
to facilitate Fc- or C3b-receptor–mediated phagocytosis of the viral particles.
CELL-MEDIATED IMMUNITY IS IMPORTANT
FOR VIRAL CONTROLAND CLEARANCE
Although antibodies have an important role in containing the spread of a virus in the
acute phases of infection, they are not usually able to eliminate the virus once
infection has occurred—particularly if the virus is capable of entering a latent state in
which its DNA is integrated into host chromosomal DNA.
Once an infection is established, cell-mediated immune mechanisms are most
important in host defense. In general, CD8+ TC cells and CD4+ TH1 cells are the
main components of cell-mediated antiviral defense, although in some cases CD4+
TC cells have also been implicated. Activated TH1 cells produce a number of
cytokines, including IL-2, IFN-γ, and TNF, that defend against viruses either directly
or indirectly.
IFN-γ acts directly by inducing an antiviral state in cells. IL-2 acts indirectly by
assisting in the recruitment of CTL precursors into an effector population. Both IL-2
and IFN-γ activate NK cells, which play an important role in host defense during the
first days of many viral infections until a specific CTL response develops. In most
viral infections, specific CTL activity arises within 3–4 days after infection, peaks by
7–10 days, and then declines.
Within 7–10 days of primary infection, most virions have been eliminated,
paralleling the development of CTLs. CTLs specific for the virus eliminate
virus-infected self-cells and thus eliminate potential sources of new virus.
The role of CTLs in defense against viruses is demonstrated by the ability of
virus-specific CTLs to confer protection for the specific virus on
nonimmune recipients by adoptive transfer. The viral specificity of the CTL
as well can be demonstrated with adoptive transfer: adoptive transfer of a
CTL clone specific for influenza virus strain X protects mice against
influenza virus X but not against influenza virus strain Y.
BACTERIAL INFECTIONS
Immunity to bacterial infections is achieved by means of antibody unless
the bacterium is capable of intracellular growth, in which case delayed-
type hypersensitivity has an important role. Bacteria enter the body
either through a number of natural routes (e.g., the respiratory tract, the
gastrointestinal tract, and the genitourinary tract) or through normally
inaccessible routes opened up by breaks in mucous membranes or skin.
Depending on the number of organismsentering and their virulence,
different levels of host defense are enlisted. If the inoculum size and the
virulence are both low, then localized tissue phagocytes may be able to
eliminate the bacteria with an innate, nonspecific defense. Larger
inoculums or organisms with greater virulence tend to induce an
adaptive, specific immune response.
IMMUNE RESPONSES TO EXTRACELLULAR AND
INTRACELLULAR BACTERIA CAN DIFFER
Infection by extracellular bacteria induces production of humoral antibodies,
which are ordinarily secreted by plasma cells in regional lymph nodes and the
submucosa of the respiratory and gastrointestinal tracts. The humoral immune
response is the main protective response against extracellular bacteria. The
antibodies act in several ways to protect the host from the invading organisms,
including removal of the bacteria and inactivation of bacterial toxins .
Extracellular bacteria can be pathogenic because they induce a localized
inflammatory response or because they produce toxins.
The toxins, endotoxin or exotoxin, can be cytotoxic but also may cause
pathogenesis in other ways. An excellent example of this is the toxin produced by
diphtheria, which exerts a toxic effect on the cell by blocking protein synthesis.
Endotoxins, such as lipopolysaccharides (LPS), are generally components of
bacterial cell walls, while exotoxins, such as diphtheria toxin, are secreted by the
bacteria. Antibody that binds to accessible antigens on the surface of a bacterium
can, together with the C3b component of complement, act as an opsonin that
increases phagocytosis and thus clearance of the bacterium .
In the case of some bacteria—notably, the gram-negative organisms—
complement activation can lead directly to lysis of the organism. Antibody-
mediated activation of the complement system can also induce localized
production of immune effector molecules that help to develop an amplified and
more effective inflammatory response. For example, the complement split
products C3a, C4a, and C5a act as anaphylatoxins, inducing local mast-cell
degranulation and thus vasodilation and the extravasation of lymphocytes and
neutrophils from the blood into tissue space . Other complement split products
serve as chemotactic factors for neutrophils and macrophages, thereby
contributing to the buildup of phagocytic cells at the site of infection.
Antibody to a bacteria toxin may bind to the toxin and neutralize it; the
antibody-toxin complexes are then cleared by phagocytic cells in the same
manner as any other antigen antibody complex. While innate immunity is not
very effective against intracellular bacterial pathogens, intracellular bacteria can
activate NK cells, which, in turn, provide an early defense against these
bacteria. Intracellular bacterial infections tend to induce a cell-mediated
immune response, specifically, delayed type hypersensitivity. In this response,
cytokines secreted by CD4+ T cells are important—notably IFN-, which
activates macrophages to kill ingested pathogens more effectively
BACTERIACAN EFFECTIVELY EVADE HOST
DEFENSE MECHANISMS
There are four primary steps in bacterial infection:
■ Attachment to host cells
■ Proliferation
■ Invasion of host tissue
■ Toxin-induced damage to host cells
Host-defense mechanisms act at each of these steps, and many bacteria have
evolved ways to circumvent some of these host defenses
Some bacteria have surface structures or molecules that enhance their ability
to attach to host cells. A number of gram-negative bacteria, for instance,
have pili (long hairlike projections), which enable them to attach to the
membrane of the intestinal or genitourinary tract . Other bacteria, such as
Bordetella pertussis, secrete adhesion molecules that attach to both the
bacterium and the ciliated epithelial cells of the upper respiratory tract
Secretory IgA antibodies specific for such bacterial structures can block
bacterial attachment to mucosal epithelial cells and are the main host defense
against bacterial attachment. However, some bacteria (e.g., Neisseria
gonorrhoeae, Haemophilus influenzae, and Neisseria meningitidis) evade the
IgA response by secreting proteases that cleave secretory IgA at the hinge
region; the resulting Fab and Fc fragments have a shortened half-life in
mucous secretions and are not able to agglutinate microorganisms.
Some bacteria evade the IgA response of the host by changing these surface
antigens. In N. gonorrhoeae, for example, pilin, the protein component of the
pili, has a highly variable structure. Variation in the pilin amino acid
sequence is generated by gene rearrangements of its coding sequence. The
pilin locus consists of one or two expressed genes and 10–20 silent genes.
Each gene is arranged into six regions called minicassettes. Pilin variation is
generated by a process of gene conversion, in which one or more
minicassettes from the silent genes replace a minicassette of the expression
gene. This process generates enormous antigenic variation, which may
contribute to the pathogenicity of N. gonorrhoeae by increasing the
likelihood that expressed pili will bind firmly to epithelial cells. In addition,
the continual changes in the pilin sequence allow the organism to evade
neutralization by IgA.
Some bacteria possess surface structures that serve to inhibit phagocytosis. A classic example is
Streptococcus pneumoniae, whose polysaccharide capsule prevents phagocytosis very
effectively. There are 84 serotypes of S. pneumoniae that differ from one another by distinct
capsular polysaccharidesDuring infection, the host produces antibody against the infecting
serotype. This antibody protects against reinfection with the same serotype but will not protect
against infection by a different serotype. In this way, S. pneumoniae can cause disease many
times in the same individual. On other bacteria, such as Streptococcus pyogenes, a surface
protein projection called the M protein inhibits phagocytosis.
Some pathogenic staphylococci are able to assemble a protective coat from host proteins.
These bacteria secrete a coagulase enzyme that precipitates a fibrin coat around them, shielding
them from phagocytic cells. Mechanisms for interfering with the complement system help
other bacteria survive. In some gram-negative bacteria, for example, long side chains on the
lipid A moiety of the cell-wall core polysaccharide help to resist complementmediated lysis.
Pseudomonas secretes an enzyme, elastase, that inactivates both the C3a and C5a
anaphylatoxins, thereby diminishing the localized inflammatory reaction. A number of bacteria
escape host defense mechanisms by their ability to survive within phagocytic cells.
Some, such as Listeria monocytogenes, do this by escaping from the phagolysosome to the
cytoplasm, which is a more favorable environment for their growth. Other bacteria, such as
Mycobacterium avium, block lysosomal fusion with the phagolysosome; and some
mycobacteria are resistant to the oxidative attack that takes place within the phagolysosome.
IMMUNE RESPONSES CAN CONTRIBUTE TO
BACTERIAL PATHOGENESIS
In some cases, disease is caused not by the bacterial pathogen itself but by the immune
response to the pathogen. Pathogen-stimulated overproduction of cytokines leads to the
symptoms of bacterial septic shock, food poisoning, and toxic-shock syndrome. For
instance, cell-wall endotoxins of some gram-negative bacteria activate macrophages,
resulting in release of high levels of IL-1 and TNF-α, which can cause septic shock. In
staphylococcal food poisoning and toxic-shock syndrome, exotoxins produced by the
pathogens function as superantigens, which can activate all T cells that express T-cell
receptors with a particular Vβ domain. The resulting overproduction of cytokines by
activated TH cells causes many of the symptoms of these diseases.
The ability of some bacteria to survive intracellularly within infected cells can result in
chronic antigenic activation of CD4+ T cells, leading to tissue destruction by a cell-
mediated response with the characteristics of a delayed-type hypersensitivity reaction .
Cytokines secreted by these activated CD4+ T cells can lead to extensive accumulation
and activation of macrophages, resulting in formation of a granuloma. The localized
concentrations of lysosomal enzymes in these granulomas can cause extensive tissue
necrosis. Much of the tissue damage seen with M. tuberculosis is due to a cell-mediated
immune response.
Immunology
Immunology

Immunology

  • 1.
    IMMUNOLOGY Presented By Soniya.S II MScBiochemistry Dkm Collage For Women Vellore
  • 2.
    The immune systemis remarkable and versatile defense system that has evolved to protect animals from invading pathogenic microorganisms and cancer. It is able to generate an enormous variety of cells and molecules capable of specifically recognizing and eliminating an apparently limitless variety of foreign invaders. These cells and molecules act together in a dynamic network whose complexity rivals that of the nervous system. Functionally, an immune response can be divided into two related activities -recognition and response. Immune recognition is remarkable for its specificity. The immune system is able to recognize subtle chemical differences that distinguish one foreign pathogen from another. Furthermore, the system is able to discriminate between foreign molecules and the body’s own cells and proteins
  • 3.
    Once a foreignorganism has been recognized, the immune system recruits a variety of cells and molecules to mount an appropriate response, called an effector response, to eliminate or neutralize the organism. In this way the system is able to convert the initial recognition event into a variety of effector responses, each uniquely suited for eliminating a particular type of pathogen.  Later exposure to the same foreign organism induces a memory response, characterized by a more rapid and heightened immune reaction that serves to eliminate the pathogen and prevent disease. The Latin term immunis, meaning “exempt,” is the source of the English word immunity, meaning the state of protection from infectious disease.
  • 4.
    HISTORICAL PERSPECTIVE Chines andturks – 15 century lady marry wortley montagu-1718 Edward jenner-1789 Louis pasteur Pouilly-le-Fort and pasteur in 1881
  • 5.
    EARLY STUDIES REVEALEDHUMORALAND CELLULAR COMPONENTS OF THE IMMUNE SYSTEM Emil von Behring and Shibsaburo Kitasato 1990 Elvin Kabat in 1930 Elie Metchnikoff in 1883 Merrill Chase in 1940 Bruce Glick in 1950
  • 6.
    THE IMMUNE SYSTEMINCLUDES INNATE AND ADAPTIVE COMPONENTS Immunity the state of protection from infectious disease has both a less specific and more specific component. The less specific component, innate immunity, provides the first line of defense against infection. Most components of innate immunity are present before the onset of infection and constitute a set of disease-resistance mechanisms that are not specific to a particular pathogen but that include cellular and molecular components that recognize classes of molecules peculiar to frequently encountered pathogens. Phagocytic cells, such as macrophages and neutrophils, barriers such as skin, and a variety of antimicrobial compounds synthesized by the host all play important roles in innate immunity. In contrast to the broad reactivity of the innate immune system, which is uniform in all members of a species, the specific component
  • 7.
    Adaptive immunity, doesnot come into play until there is an antigenic challenge to the organism. Adaptive immunity responds to the challenge with a high degree of specificity as well as the remarkable property of “memory.” Typically, there is an adaptive immune response against an antigen within five or six days after the initial exposure to that antigen. Exposure to the same antigen some time in the future results in a memory response: the immune response to the second challenge occurs more quickly than the first, is stronger, and is often more effective in neutralizing and clearing the pathogen. The major agents of adaptive immunity are lymphocytes and the antibodies and other molecules they produce. Because adaptive immune responses require some time to marshal, innate immunity provides the first line of defense during the critical period just after the host’s exposure to a pathogen. In general, most of the microorganisms encountered by a healthy individual are readily cleared within a few days by defense mechanisms of the innate immune system before they activate the adaptive immune system.
  • 8.
    INNATE IMMUNITY Innate immunitycan be seen to comprise four types of defensive barriers: anatomic, physiologic, phagocytic, and inflammatory (Table 1-2). Type Mechanism Anatomic barriers Skin Mechanical barrier retards entry of microbes. Acidic environment (pH 3–5) retards growth of microbes Mucous membranes Normal flora compete with microbes for attachment sites and nutrients. Mucus entraps foreign microorganisms. Cilia propel microorganisms out of body Physiologic barriers Temperature Normal body temperature inhibits growth of some pathogens. Fever response inhibits growth of some pathogens. Low Ph Acidity of stomach contents kills most ingested microorganisms
  • 9.
    Chemical mediators Lysozymecleaves bacterial cell wall. Interferon induces antiviral state in uninfected cells. Complement lyses microorganisms or facilitates phagocytosis. Toll-like receptors recognize microbial molecules, signal cell to secrete immunostimulatory cytokines. Collectins disrupt cell wall of pathogen. Phagocytic/endocytic barriers Various cells internalize (endocytose) and break down foreign macromolecules. Specialized cells (blood monocytes, neutrophils, tissue macrophages) internalize (phagocytose), kill, and digest whole microorganisms. nflammatory barriers Tissue damage and infection induce leakage of vascular fluid, containing serum proteins with antibacterial activity, and influx of phagocytic cells into the affected area
  • 10.
    A variety ofsoluble factors contribute to innate immunity, among them the soluble proteins lysozyme, interferon, and complement. -Lysozyme, a hydrolytic enzyme found in mucous secretions and in tears, is able to cleave the peptidoglycan layer of the bacterial cell wall. -Interferon comprises a group of proteins produced by virus-infected cells. Among the many functions of the interferons is the ability to bind to nearby cells and induce a generalized antiviral state. -Complement, is a group of serum proteins that circulate in an inactive state
  • 12.
    CELLS THAT INGESTANDDESTROY PATHOGENS MAKE UPA PHAGOCYTIC BARRIER TO INFECTION  Another important innate defense mechanism is the ingestion of extracellular particulate material by phagocytosis. Phagocytosis is one type of endocytosis, the general term for the uptake by a cell of material from its environment. In phagocytosis, a cell’s plasma membrane expands around the particulate material, which may include whole pathogenic microorganisms, to form large vesicles called phagosomes . Most phagocytosis is conducted by specialized cells, such as blood monocytes, neutrophils, and tissue macrophages . Most cell types are capable of other forms of endocytosis, such as receptor- mediated endocytosis, in which extracellular molecules are internalized after binding by specific cellular receptors, and pinocytosis, the process by which cells take up fluid from the surrounding medium along with any molecules contained in it.
  • 14.
    INFLAMMATION REPRESENTS ACOMPLEX SEQUENCE OF EVENTS THAT STIMULATES IMMUNE RESPONSES Tissue damage caused by a wound or by an invading pathogenic microorganism induces a complex sequence of events collectively known as the inflammatory response. As described above, a molecular component of a microbe, such as LPS, may trigger an inflammatory response via interaction with cell surface receptors. The end result of inflammation may be the marshalling of a specific immune response to the invasion or clearance of the invader by components of the innate immune system. Many of the classic features of the inflammatory response were described as early as 1600 BC, in Egyptian papyrus writings. In the first century AD, the Roman physician Celsus described the “four cardinal signs of inflammation” as rubor (redness), tumor (swelling), calor (heat), and dolor (pain). In the second century AD, another physician, Galen, added a fifth sign: functio laesa (loss of function).
  • 15.
    The cardinal signsof inflammation reflect the three major events of an inflammatory response 1. Vasodilation—an increase in the diameter of blood vessels—of nearby capillaries occurs as the vessels that carry blood away from the affected area constrict, resulting in engorgement of the capillary network. The engorged capillaries are responsible for tissue redness (erythema) and an increase in tissue temperature. 2. An increase in capillary permeability facilitates an influx of fluid and cells from the engorged capillaries into the tissue. The fluid that accumulates (exudate) has a much higher protein content than fluid normally released from the vasculature. Accumulation of exudate contributes to tissue swelling (edema)
  • 16.
    3. Influx ofphagocytes from the capillaries into the tissues is facilitated by the increased permeability of the capillaries. The emigration of phagocytes is a multistep process that includes adherence of the cells to the endothelial wall of the blood vessels (margination), followed by their emigration between the capillaryendothelial cells into the tissue (diapedesis or extravasation), and, finally, their migration through the tissue to the site of the invasion (chemotaxis). As phagocytic cells accumulate at the site and begin to phagocytose bacteria, they release lytic enzymes, which can damage nearby healthy cells. The accumulation of dead cells, digested material, and fluid forms a substance called pus.
  • 17.
    ADAPTIVE IMMUNITY Adaptive immunityis capable of recognizing and selectively eliminating specific foreign microorganisms and molecules (i.e., foreign antigens). Unlike innate immune responses, adaptive immune responses are not the same in all members of a species but are reactions to specific antigenic challenges. Adaptive immunity displays four characteristic attributes: Antigenic specificity Diversity Immunologic memory Self/nonself recognition -The antigenic specificity of the immune system permits it to distinguish subtle differences among antigens. Antibodies can distinguish between two protein molecules that differ in only a single amino acid. -The immune system is capable of generating tremendous diversity in its recognition molecules, allowing it to recognize billions of unique structures on foreign antigens.
  • 18.
    -Once the immunesystem has recognized and responded to an antigen, it exhibits immunologic memory; that is, a second encounter with the same antigen induces a heightened state of immune reactivity. Because of this attribute, the immune system can confer life-long immunity to many infectious agents after an initial encounter. -Finally, the immune system normally responds only to foreign antigens, indicating that it is capable of self/nonself recognition. The ability of the immune system to distinguish self from nonself and respond only to nonself molecules is essential, for, as described below, the outcome of an inappropriate response to self molecules can be fatal.
  • 19.
    Adaptive immunity isnot independent of innate immunity. The phagocytic cells crucial to nonspecific immune responses are intimately involved in activating the specific immune response. Conversely, various soluble factors produced by a specific immune response have been shown to augment the activity of these phagocytic cells. As an inflammatory response develops, for example, soluble mediators are produced that attract cells of the immune system. The immune response will, in turn, serve to regulate the intensity of the inflammatory response. Through the carefully regulated interplay of adaptive and innate immunity, the two systems work together to eliminate a foreign invader.
  • 20.
    THE ADAPTIVE IMMUNESYSTEM REQUIRES COOPERATION BETWEEN LYMPHOCYTES AND ANTIGEN-PRESENTING CELLS  An effective immune response involves two major groups of cells: T lymphocytes and antigen-presenting cells.  Lymphocytes are one of many types of white blood cells produced in the bone marrow by the process of hematopoiesis .  Lymphocytes leave the bone marrow, circulate in the blood and lymphatic systems, and reside in various lymphoid organs. Because they produce and display antigenbinding cell-surface receptors, lymphocytes mediate the defining immunologic attributes of specificity, diversity, memory, and self/nonself recognition.  The two major populations of lymphocytes-B lymphocytes (B cells) and T lymphocytes (T cells)
  • 21.
    B LYMPHOCYTES B cell- Antibodies Receptor B cell-Small navie B lymphocytes (without antigen) Induces cell cycle entry(antigen activation) lymphoblasts (DNA synthesis) Cell division Effector cell Memory cell Effector B cells called plasma cells. . Plasma cells produce the antibody in a form that can be secreted and have little or no membrane-bound antibody. Although plasma cells live for only a few days, they secrete enormous amounts of antibody during this time. It has been estimated that a single plasma cell can secrete more than 2000 molecules of antibody per second. Secreted antibodies are the major effector molecules of humoral immunity Memory B cells have a longer life span than naive cells, and they express the same membrane-bound antibody as their parent B cell.
  • 24.
    T LYMPHOCYTES T –cell arise in bone marrow and mature in thymus (migration) T-cell have receptor – CD4 & CD8 receptor(express a unique antigen-binding molecule, called the T-cell receptor, on its membrane.) T-cell receptors can recognize only antigen that is bound to cell-membrane proteins called major histocompatibility complex (MHC) molecules. T lymphocytes Class I MHG or CD8 &Tc (nucleoted cell) Class II MHGor CD4&TH(APC) Class I MHC molecules, which are expressed by nearly all nucleated cells of vertebrate species, consist of a heavy chain linked to a small invariant protein called β2-microglobulin Class II MHC molecules, which consist of an alpha and a beta glycoprotein chain, are expressed only by antigen-presenting cells. When a naive T cell encounters antigen combined with a MHC molecule on a cell, the T cell proliferates and differentiates into memory T cells and various effector T cells
  • 26.
    ANTIGEN-PRESENTING CELLS Activation ofboth the humoral and cell-mediated branches of the immune system requires cytokines produced by TH cells. It is essential that activation of TH cells themselves be carefully regulated, because an inappropriate T-cell response to self- components can have fatal autoimmune consequences. To ensure carefully regulated activation of TH cells, they can recognize only antigen that is displayed together with class MHC II molecules on the surface of antigen-presenting cells (APCs). These specialized cells, which include macrophages, B lymphocytes, and dendritic cells, are distinguished by two properties: (1) they express class II MHC molecules on their membranes, and (2) they are able to deliver a co-stimulatory signal that is necessary for TH-cell activation. Antigen-presenting cells first internalize antigen, either by phagocytosis or by endocytosis, and then display a part of that antigen on their membrane bound to a class II MHC molecule. The TH cell recognizes and interacts with the antigen–class II MHC molecule complex on the membrane of the antigen-presenting cell . An additional costimulatory signal is then produced by the antigen-presenting cell, leading to activation of the TH cell
  • 27.
    HUMORAL IMMUNITY BUTNOT CELLULAR IMMUNITY IS TRANSFERRED WITH ANTIBODY EFECTOR B-CELL Humoral branch of the immune system is –B cell Prolifercationand differentiation into antibody-secreting plasma cell Antibody functionas the effector of the humoral response by binding to antigen and neutralizing 1.Cross link several antigen to form clusters-ingested by phagocytic cell 2.Activation of complement system-lysis 3.Neutralize toxic or viral-coating them-prevents binding to host cell EFFECTOR T- CELL Effector t cell generated in the response to antigen are responsible for the cell- mediated Both activated TH cell+cytotoxic T Lymphocytes (CTLs) serves as effector cell in cell- imediated immune reaction. Cytokines secreted by TH cells can activate various phagocytic cell-phagocutose&kill microorganism more effectively CTLs participate –play important role in the killing of virus infected cell ,tumor cell & altered self cell
  • 28.
    ANTIGEN IS RECOGNIZEDDIFFERENTLY BY B AND T LYMPHOCYTES Antigens, which are generally very large and complex, are not recognized in their entirety by lymphocytes. Instead, both B and T lymphocytes recognize discrete sites on the antigen called antigenic determinants, or epitopes. Epitopes are the immunologically active regions on a complex antigen, the regions that actually bind to B-cell or T-cell receptors. Although B cells can recognize an epitope alone, T cells can recognize an epitope only when it is associated with an MHC molecule on the surface of a self-cell (either an antigen-presenting cell or an altered self- cell). Each branch of the immune system is therefore uniquely suited to recognize antigen in a different milieu. The humoral branch (B cells) recognizes an enormous variety of epitopes: those displayed on the surfaces of bacteria or viral particles, as well as those displayed on soluble proteins, glycoproteins, polysaccharrides, or lipopolysaccharides that have been released from invading pathogens. The cell-mediated branch (T cells) recognizes protein epitopes displayed together with MHC molecules on self-cells, including altered self-cells such as virus-infected self-cells and cancerous cells. Thus, four related but distinct cell-membrane molecules are responsible for antigen recognition by the immune system: ■ Membrane-bound antibodies on B cells ■ T-cell receptors ■ Class I MHC molecules ■ Class II MHC molecules Each of these molecules plays a unique role in antigen recognition, ensuring that the immune system can recognize and respond to the different types of antigen that it encounters.
  • 30.
    COMPLEXANTIGENS ARE DEGRADED(PROCESSED) AND DISPLAYED (PRESENTED) WITH MHC MOLECULES ON THE CELL SURFACE In order for a foreign protein antigen to be recognized by a T cell, it must be degraded into small antigenic peptides that form complexes with class I or class II MHC molecules. This conversion of proteins into MHC-associated peptide fragments is called antigen processing and presentation. Whether a particular antigen will be processed and presented together with class I MHC or class II MHC molecules appears to be determined by the route that the antigen takes to enter a cell  Exogenous pathway  Endogenous pathway
  • 31.
    EXOGENOUS PATHWAY Exogenous antigenis produced outside of the host cell and enters the cell by endocytosis or phagocytosis. Antigen presenting cells (macrophages, dendritic cells, and B cells) degrade ingested exogenous antigen into peptide fragments within the endocytic processing pathway. Experiments suggest that class II MHC molecules are expressed within the endocytic processing pathway and that peptides produced by degradation of antigen in this pathway bind to the cleft within the class II MHC molecules. The MHC molecules bearing the peptide are then exported to the cell surface. Since expression of class II MHC molecules is limited to antigen-presenting cells, presentation of exogenous peptide– class II MHC complexes is limited to these cells. T cells displaying CD4 recognize antigen combined with class II MHC molecules and thus are said to be class II MHC restricted. These cells generally function as T helper cells
  • 33.
    ENDOGENOUS PATHWAY Endogenous antigenis produced within the host cell itself. Two common examples are viral proteins synthesized within virus-infected host cells and unique proteins synthesized by cancerous cells. Endogenous antigens are degraded into peptide fragments that bind to class I MHC molecules within the endoplasmic reticulum. The peptide–class I MHC complex is then transported to the cell membrane. Since all nucleated cells express class I MHC molecules, all cells producing endogenous antigen use this route to process the antigen. T cells displaying CD8 recognize antigen associated with class I MHC molecules and thus are said to be class I MHC restricted. These cytotoxic T cells attack and kill cells displaying the antigen–MHC class I complexes for which their receptors are specific
  • 35.
    ANTIGEN SELECTION OFLYMPHOCYTES CAUSES CLONAL EXPANSION A mature immunocompetent animal contains a large number of antigen- reactive clones of T and B lymphocytes; the antigenic specificity of each of these clones is determined by the specificity of the antigen-binding receptor on the membrane of the clone’s lymphocytes. As noted above, the specificity of each T and B lymphocyte is determined before its contact with antigen by random gene rearrangements during maturation in the thymus or bone marrow. The role of antigen becomes critical when it interacts with and activates mature, antigenically committed T and B lymphocytes, bringing about expansion of the population of cells with a given antigenic specificity. In this process of clonal selection, an antigen binds to a particular T or B cell and stimulates it to divide repeatedly into a clone of cells with the same antigenic specificity as the original parent cell . Clonal selection provides a framework for understanding the specificity and self/nonself recognition that is characteistic of adaptive immunity. Specificity is shown because only lymphocytes whose receptors are specific for a given epitope on an antigen will be clonally expanded and thus mobilized for an immune response. Self/nonself discrimination is accomplished by the elimination, during development, of lymphocytes bearing self-reactive receptors or by the functional suppression of these cells in adults.
  • 36.
    Immunologic memory alsois a consequence of clonal selection. During clonal selection, the number of lymphocytes specific for a given antigen is greatly amplified. Moreover, many of these lymphocytes, referred to as memory cells, appear to have a longer life span than the naive lymphocytes from which they arise. The initial encounter of a naive immunocompetent lymphocyte with an antigen induces a primary response; a later contact of the host with antigen will induce a more rapid and heightened secondary response. The amplified population of memory cells accounts for the rapidity and intensity that distinguishes a secondary response from the primary response.
  • 37.
    a) When ananimal is injected with an antigen, it produces a primary serum antibody response of low magnitude and short duration, peaking at about 10–17 days. A second immunization with the same antigen results in a secondary response that is greater in magnitude, peaks in less time (2–7 days), and lasts longer (months to years) than the primary response. Compare the secondary response to antigen A with the primary response to antigen B administered to the same mice. DIFFERENCES IN THE PRIMARYAND SECONDARY RESPONSE TO INJECTEDANTIGEN (HUMORALRESPONSE)AND TOASKIN GRAFT (CELL-MEDIATED RESPONSE) REFLECT THE PHENOMENON OF IMMUNOLOGIC MEMORY
  • 38.
    (b) Results froma hypothetical experiment in which skin grafts from strain C mice are transplanted to 20 mice of strain A; the grafts are rejected in about 10–14 days. The 20 mice are rested for 2 months and then 10 are given strain C grafts and the other 10 are given skin from strain B. Mice previously exposed to strain C skin reject C grafts much more vigorously and rapidly than the grafts from strain B. Note that the rejection of the B graft follows a time course similar to that of the first strain C graft
  • 39.
    COMPARISON OF ADAPTIVEANDINNATE IMMUNITY INNATE ADAPTIVE Response time Hours Days Specificity Limited and fixed Highly diverse, improves during the course of immune response Response response infection to Identical to primary response Much more rapid than repeat primary response
  • 40.
    IMMUNE DYSFUNCTIONAND ITS CONSEQUENCES Sometimesthe immune system fails to protect the host adequately or misdirects its activities to cause discomfort, debilitating disease, or even death. There are several common manifestations of immune dysfunction: ■ Allergy and asthma ■ Graft rejection and graft-versus-host disease ■ Autoimmune disease ■ Immunodeficiency Allergy and asthma are results of inappropriate immune responses, often to common antigens such as plant pollen, food, or animal dander. The possibility that certain substances increased sensitivity rather than protection was recognized in about 1902 by Charles Richet, who attempted to immunize dogs against the toxins of a type of jellyfish, Physalia. He and his colleague Paul Portier observed that dogs exposed to sublethal doses of the toxin reacted almost instantly, and fatally, to subsequent challenge with minute amounts of the toxin. Richet concluded that a successful immunization or vaccination results in phylaxis, or protection, and that an opposite result may occur—anaphylaxis—in which exposure to antigen can result in a potentially lethal sensitivity to the antigen if the exposure is repeated. Richet received the Nobel Prize in 1913 for his discovery of the anaphylactic response.
  • 41.
    When the immunesystem encounters foreign cells or tissue, it responds strongly to rid the host of the invaders. However, in some cases, the transplantation of cells or an organ from another individual, although viewed by the immune system as a foreign invasion, may be the only possible treatment for disease. For example, it is estimated that more than 60,000 persons in the United States alone could benefit from a kidney transplant. Because the immune system will attack and reject any transplanted organ that it does not recognize as self, it is a serious barrier to this potentially life-saving treatment. An additional danger in transplantation is that any transplanted cells with immune function may view the new host as nonself and react against it. This reaction, which is termed graft-versus-host disease, can be fatal. The rejection reaction and graft-versus-host disease can be suppressed by drugs, but this type of treatment suppresses all immune function, so that the host is no longer protected by its immune system and becomes susceptible to infectious diseases.
  • 42.
    In certain individuals,the immune system malfunctions by losing its sense of self and nonself, which permits an immune attack upon the host. This condition, autoimmunity, can cause a number of chronic debilitating diseases. The symptoms of autoimmunity differ depending on which tissues and organs are under attack. For example, multiple sclerosis is due to an autoimmune attack on the brain and central nervous system, Crohn’s disease is an attack on the tissues in the gut, and rheumatoid arthritis is an attack on joints of the arms and legs. The genetic and environmental factors that trigger and sustain autoimmune disease are very active areas of immunologic research, as is the search for improved treatments. If any of the many components of innate or specific immunity is defective because of genetic abnormality, or if any immune function is lost because of damage by chemical, physical, or biological agents, the host suffers from immunodeficiency. The severity of the immunodeficiency disease depends on the number of affected components.
  • 43.
    A common typeof immunodeficiency in North America is a selective immunodeficiency in which only one type of immunoglobulin, IgA, is lacking; the symptoms may be minor or even go unnoticed. In contrast, a rarer immunodeficiency called severe combined immunodeficiency (SCID), which affects both B and T cells, if untreated, results in death from infection at an early age. Since the 1980s, the most common form of immunodeficiency has been acquired immune deficiency syndrome, or AIDS, which results from infection with the retrovirus human immunodeficiency virus, or HIV. In AIDS, T helper cells are infected and destroyed by HIV, causing a collapse of the immune system
  • 44.
    IMMUNE RESPONSE TOINFECTIOUS DISEASES One of the first and most important features of host innate immunity is the barrier provided by the epithelial surfaces of the skin and the lining of the gut. The difficulty of penetrating these epithelial barriers ensures that most pathogens never gain productive entry into the host. In addition to providing a physical barrier to infection, the epithelia also produce chemicals that are useful in preventing infection. The secretion of gastric enzymes by specialized epithelial cells lowers the pH of the stomach and upper gastrointestinal tract, and other specialized cells in the gut produce antibacterial peptides. A major feature of innate immunity is the presence of the normal gut flora, which can competitively inhibit the binding of pathogens to gut epithelial cells. Innate responses can also block the establishment of infection. For example, the cell walls of some gram-positive bacteria contain a peptidoglycan that activates the alternative complement pathway, resulting in the generation of C3b, which opsonizes bacteria and enhances phagocytosis
  • 45.
    Some bacteria produceendotoxins such as LPS, which stimulate the production of cytokines such as TNF-, IL-1, and IL-6 by macrophages or endothelial cells. These cytokines can activate macrophages. Phagocytosis of bacteria by macrophages and other phagocytic cells is another highly effective line of innate defense. However, some types of bacteria that commonly grow intracellularly have developed mechanisms that allow them to resist degradation within the phagocyte. Viruses are well known for the stimulation of innate responses. In particular, many viruses induce the production of interferons, which can inhibit viral replication by inducing an antiviral response. Viruses are also controlled by NK cells. As described in Chapter 14, NK cells frequently form the first line of defense against viral infections.
  • 46.
    VIRAL INFECTIONS A numberof specific immune effector mechanisms, together with nonspecific defense mechanisms, are called into play to eliminate an infecting virus . At the same time, the virus acts to subvert one or more of these mechanisms to prolong its own survival. The outcome of the infection depends on how effectively the host’s defensive mechanisms resist the offensive tactics of the virus. 1. The innate immune response to viral infection is primarily through the induction of type I interferons (IFN-α and IFN-β) and the activation of NK cells. 2. Double stranded RNA (dsRNA) produced during the viral life cycle can induce the expression of IFN-α and IFN-β by the infected cell. 3. Macrphages, monocytes, and fibroblasts also are capable of synthesizing these cytokines, but the mechanisms that induce the production of type I interferons in these cells are not completely understood.
  • 48.
    4.IFN-α and IFN-βcan induce an antiviral response or resistance to viral replication by binding to the IFNα/β receptor. Once bound, IFN-α and IFN-β activate the JAK-STAT pathway, which in turn induces the transcription of several genes. 5.One of these genes encodes an enzyme known as 2’-5’-oligo-adenylate synthetase [2-5(A) synthetase], which activates a ribonuclease (RNAse L) that degrades viral RNA. Other genes activated by IFN-α/β binding to its receptor also contribute to the inhibition of viral replication. For example, IFN-α/β binding induces a specific protein kinase called dsRNA-dependent protein kinase (PKR), which inactivates protein synthesis, thus blocking viral replication in infected cells. 6.The binding of IFN-α and IFN-β to NK cells induces lytic activity, making them very effective in killing virally infected cells. The activity of NK cells is also greatly enhanced by IL-12, a cytokine that is produced very early in a response to viral infection.
  • 50.
    MANY VIRUSES ARENEUTRALIZED BY ANTIBODIES Antibodies specific for viral surface antigens . Antibodies are particularly effective in protecting against infection if they are localized at the site of viral entry into the body. Most viruses express surface receptor molecules that enable them to initiate infection by binding to specific host-cell membrane molecules. For example, influenza virus binds to sialic acid residues in cellmembrane glycoproteins and glycolipids; rhinovirus binds to intercellular adhesion molecules (ICAMs); and Epstein-Barr virus binds to type 2 complement receptors on B cells. If antibody to the viral receptor is produced, it can block infection altogether by preventing the binding of viral particles to host cells. Secretory IgA in mucous secretions plays an important role in host defense against viruses by blocking viral attachment to mucosal epithelial cells. The advantage of the attenuated oral polio vaccine, is that it induces production of secretory IgA, which effectively blocks attachment of poliovirus along the gastrointestinal tract. Viral neutralization by antibody sometimes involves mechanisms that operate after viral attachment to host cells. In some cases, antibodies may block viral penetration by binding to epitopes that are necessary to mediate fusion of the viral envelope with the plasma membrane. If the induced antibody is of a complement-activating isotype, lysis of enveloped virions can ensue. Antibody or complement can also agglutinate viral particles and function as an opsonizing agent to facilitate Fc- or C3b-receptor–mediated phagocytosis of the viral particles.
  • 51.
    CELL-MEDIATED IMMUNITY ISIMPORTANT FOR VIRAL CONTROLAND CLEARANCE Although antibodies have an important role in containing the spread of a virus in the acute phases of infection, they are not usually able to eliminate the virus once infection has occurred—particularly if the virus is capable of entering a latent state in which its DNA is integrated into host chromosomal DNA. Once an infection is established, cell-mediated immune mechanisms are most important in host defense. In general, CD8+ TC cells and CD4+ TH1 cells are the main components of cell-mediated antiviral defense, although in some cases CD4+ TC cells have also been implicated. Activated TH1 cells produce a number of cytokines, including IL-2, IFN-γ, and TNF, that defend against viruses either directly or indirectly. IFN-γ acts directly by inducing an antiviral state in cells. IL-2 acts indirectly by assisting in the recruitment of CTL precursors into an effector population. Both IL-2 and IFN-γ activate NK cells, which play an important role in host defense during the first days of many viral infections until a specific CTL response develops. In most viral infections, specific CTL activity arises within 3–4 days after infection, peaks by 7–10 days, and then declines.
  • 52.
    Within 7–10 daysof primary infection, most virions have been eliminated, paralleling the development of CTLs. CTLs specific for the virus eliminate virus-infected self-cells and thus eliminate potential sources of new virus. The role of CTLs in defense against viruses is demonstrated by the ability of virus-specific CTLs to confer protection for the specific virus on nonimmune recipients by adoptive transfer. The viral specificity of the CTL as well can be demonstrated with adoptive transfer: adoptive transfer of a CTL clone specific for influenza virus strain X protects mice against influenza virus X but not against influenza virus strain Y.
  • 53.
    BACTERIAL INFECTIONS Immunity tobacterial infections is achieved by means of antibody unless the bacterium is capable of intracellular growth, in which case delayed- type hypersensitivity has an important role. Bacteria enter the body either through a number of natural routes (e.g., the respiratory tract, the gastrointestinal tract, and the genitourinary tract) or through normally inaccessible routes opened up by breaks in mucous membranes or skin. Depending on the number of organismsentering and their virulence, different levels of host defense are enlisted. If the inoculum size and the virulence are both low, then localized tissue phagocytes may be able to eliminate the bacteria with an innate, nonspecific defense. Larger inoculums or organisms with greater virulence tend to induce an adaptive, specific immune response.
  • 54.
    IMMUNE RESPONSES TOEXTRACELLULAR AND INTRACELLULAR BACTERIA CAN DIFFER Infection by extracellular bacteria induces production of humoral antibodies, which are ordinarily secreted by plasma cells in regional lymph nodes and the submucosa of the respiratory and gastrointestinal tracts. The humoral immune response is the main protective response against extracellular bacteria. The antibodies act in several ways to protect the host from the invading organisms, including removal of the bacteria and inactivation of bacterial toxins . Extracellular bacteria can be pathogenic because they induce a localized inflammatory response or because they produce toxins. The toxins, endotoxin or exotoxin, can be cytotoxic but also may cause pathogenesis in other ways. An excellent example of this is the toxin produced by diphtheria, which exerts a toxic effect on the cell by blocking protein synthesis. Endotoxins, such as lipopolysaccharides (LPS), are generally components of bacterial cell walls, while exotoxins, such as diphtheria toxin, are secreted by the bacteria. Antibody that binds to accessible antigens on the surface of a bacterium can, together with the C3b component of complement, act as an opsonin that increases phagocytosis and thus clearance of the bacterium .
  • 55.
    In the caseof some bacteria—notably, the gram-negative organisms— complement activation can lead directly to lysis of the organism. Antibody- mediated activation of the complement system can also induce localized production of immune effector molecules that help to develop an amplified and more effective inflammatory response. For example, the complement split products C3a, C4a, and C5a act as anaphylatoxins, inducing local mast-cell degranulation and thus vasodilation and the extravasation of lymphocytes and neutrophils from the blood into tissue space . Other complement split products serve as chemotactic factors for neutrophils and macrophages, thereby contributing to the buildup of phagocytic cells at the site of infection. Antibody to a bacteria toxin may bind to the toxin and neutralize it; the antibody-toxin complexes are then cleared by phagocytic cells in the same manner as any other antigen antibody complex. While innate immunity is not very effective against intracellular bacterial pathogens, intracellular bacteria can activate NK cells, which, in turn, provide an early defense against these bacteria. Intracellular bacterial infections tend to induce a cell-mediated immune response, specifically, delayed type hypersensitivity. In this response, cytokines secreted by CD4+ T cells are important—notably IFN-, which activates macrophages to kill ingested pathogens more effectively
  • 56.
    BACTERIACAN EFFECTIVELY EVADEHOST DEFENSE MECHANISMS There are four primary steps in bacterial infection: ■ Attachment to host cells ■ Proliferation ■ Invasion of host tissue ■ Toxin-induced damage to host cells Host-defense mechanisms act at each of these steps, and many bacteria have evolved ways to circumvent some of these host defenses Some bacteria have surface structures or molecules that enhance their ability to attach to host cells. A number of gram-negative bacteria, for instance, have pili (long hairlike projections), which enable them to attach to the membrane of the intestinal or genitourinary tract . Other bacteria, such as Bordetella pertussis, secrete adhesion molecules that attach to both the bacterium and the ciliated epithelial cells of the upper respiratory tract
  • 57.
    Secretory IgA antibodiesspecific for such bacterial structures can block bacterial attachment to mucosal epithelial cells and are the main host defense against bacterial attachment. However, some bacteria (e.g., Neisseria gonorrhoeae, Haemophilus influenzae, and Neisseria meningitidis) evade the IgA response by secreting proteases that cleave secretory IgA at the hinge region; the resulting Fab and Fc fragments have a shortened half-life in mucous secretions and are not able to agglutinate microorganisms. Some bacteria evade the IgA response of the host by changing these surface antigens. In N. gonorrhoeae, for example, pilin, the protein component of the pili, has a highly variable structure. Variation in the pilin amino acid sequence is generated by gene rearrangements of its coding sequence. The pilin locus consists of one or two expressed genes and 10–20 silent genes. Each gene is arranged into six regions called minicassettes. Pilin variation is generated by a process of gene conversion, in which one or more minicassettes from the silent genes replace a minicassette of the expression gene. This process generates enormous antigenic variation, which may contribute to the pathogenicity of N. gonorrhoeae by increasing the likelihood that expressed pili will bind firmly to epithelial cells. In addition, the continual changes in the pilin sequence allow the organism to evade neutralization by IgA.
  • 58.
    Some bacteria possesssurface structures that serve to inhibit phagocytosis. A classic example is Streptococcus pneumoniae, whose polysaccharide capsule prevents phagocytosis very effectively. There are 84 serotypes of S. pneumoniae that differ from one another by distinct capsular polysaccharidesDuring infection, the host produces antibody against the infecting serotype. This antibody protects against reinfection with the same serotype but will not protect against infection by a different serotype. In this way, S. pneumoniae can cause disease many times in the same individual. On other bacteria, such as Streptococcus pyogenes, a surface protein projection called the M protein inhibits phagocytosis. Some pathogenic staphylococci are able to assemble a protective coat from host proteins. These bacteria secrete a coagulase enzyme that precipitates a fibrin coat around them, shielding them from phagocytic cells. Mechanisms for interfering with the complement system help other bacteria survive. In some gram-negative bacteria, for example, long side chains on the lipid A moiety of the cell-wall core polysaccharide help to resist complementmediated lysis. Pseudomonas secretes an enzyme, elastase, that inactivates both the C3a and C5a anaphylatoxins, thereby diminishing the localized inflammatory reaction. A number of bacteria escape host defense mechanisms by their ability to survive within phagocytic cells. Some, such as Listeria monocytogenes, do this by escaping from the phagolysosome to the cytoplasm, which is a more favorable environment for their growth. Other bacteria, such as Mycobacterium avium, block lysosomal fusion with the phagolysosome; and some mycobacteria are resistant to the oxidative attack that takes place within the phagolysosome.
  • 60.
    IMMUNE RESPONSES CANCONTRIBUTE TO BACTERIAL PATHOGENESIS In some cases, disease is caused not by the bacterial pathogen itself but by the immune response to the pathogen. Pathogen-stimulated overproduction of cytokines leads to the symptoms of bacterial septic shock, food poisoning, and toxic-shock syndrome. For instance, cell-wall endotoxins of some gram-negative bacteria activate macrophages, resulting in release of high levels of IL-1 and TNF-α, which can cause septic shock. In staphylococcal food poisoning and toxic-shock syndrome, exotoxins produced by the pathogens function as superantigens, which can activate all T cells that express T-cell receptors with a particular Vβ domain. The resulting overproduction of cytokines by activated TH cells causes many of the symptoms of these diseases. The ability of some bacteria to survive intracellularly within infected cells can result in chronic antigenic activation of CD4+ T cells, leading to tissue destruction by a cell- mediated response with the characteristics of a delayed-type hypersensitivity reaction . Cytokines secreted by these activated CD4+ T cells can lead to extensive accumulation and activation of macrophages, resulting in formation of a granuloma. The localized concentrations of lysosomal enzymes in these granulomas can cause extensive tissue necrosis. Much of the tissue damage seen with M. tuberculosis is due to a cell-mediated immune response.